BHARAT IMMUNOLOGICALS Price to Sales vs. Price to Book

For BHARAT IMMUNOLOGICALS profitability analysis, we use financial ratios and fundamental drivers that measure the ability of BHARAT IMMUNOLOGICALS to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well BHARAT IMMUNOLOGICALS BIOLOG utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between BHARAT IMMUNOLOGICALS's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of BHARAT IMMUNOLOGICALS BIOLOG over time as well as its relative position and ranking within its peers. Check out Trending Equities.

Search Current Profitability Trends 

 
Refresh
Please note, there is a significant difference between BHARAT IMMUNOLOGICALS's value and its price as these two are different measures arrived at by different means. Investors typically determine BHARAT IMMUNOLOGICALS value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BHARAT IMMUNOLOGICALS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

BHARAT IMMUNOLOGICALS Price to Book vs. Price to Sales Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining BHARAT IMMUNOLOGICALS's current stock value. Our valuation model uses many indicators to compare BHARAT IMMUNOLOGICALS value to that of its competitors to determine the firm's financial worth.
BHARAT IMMUNOLOGICALS BIOLOG is number one stock in price to sales category among related companies. It is number one stock in price to book category among related companies fabricating about  2.47  of Price to Book per Price to Sales.

BHARAT Price to Book vs. Price to Sales

Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
BHARAT IMMUNOLOGICALS 
P/S 
 = 
MV Per Share 
Revenue Per Share 
0.30 X
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
BHARAT IMMUNOLOGICALS 
P/B 
 = 
MV Per Share 
BV Per Share 
0.74 X
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.

BHARAT Price to Book Comparison

BHARAT IMMUNOLOGICALS Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in BHARAT IMMUNOLOGICALS, profitability is also one of the essential criteria for including it into their portfolios because, without profit, BHARAT IMMUNOLOGICALS will eventually generate negative long term returns. The profitability progress is the general direction of BHARAT IMMUNOLOGICALS's change in net profit over the period of time. It can combine multiple indicators of BHARAT IMMUNOLOGICALS, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Bharat Immunologicals Biologicals Corporation Limited, a biotechnology company, manufactures and markets a range of pharmaceuticals products in India. The company was founded in 1989 and is based in Bulandshahr, India. BHARAT IMMUNOLOGICALS operates under Biotechnology classification in India and is traded on Bombay Stock Exchange.

BHARAT Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on BHARAT IMMUNOLOGICALS. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of BHARAT IMMUNOLOGICALS position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the BHARAT IMMUNOLOGICALS's important profitability drivers and their relationship over time.

Use BHARAT IMMUNOLOGICALS in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BHARAT IMMUNOLOGICALS position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BHARAT IMMUNOLOGICALS will appreciate offsetting losses from the drop in the long position's value.

BHARAT IMMUNOLOGICALS Pair Trading

BHARAT IMMUNOLOGICALS BIOLOG Pair Trading Analysis

Correlation analysis and pair trading evaluation for Twitter and Omnicom Group. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  

Use Investing Themes to Complement your BHARAT IMMUNOLOGICALS position

In addition to having BHARAT IMMUNOLOGICALS in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Heavy Metals Thematic Idea Now

Heavy Metals
Heavy Metals Theme
Companies involved in mining, production, and distribution of various industrial metals and minerals. Heavy Metals theme has 30 constituents.
View All  Next Launch Heavy Metals
Check out Trending Equities. Note that the BHARAT IMMUNOLOGICALS information on this page should be used as a complementary analysis to other BHARAT IMMUNOLOGICALS's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Tools for BHARAT Stock

When running BHARAT IMMUNOLOGICALS price analysis, check to measure BHARAT IMMUNOLOGICALS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BHARAT IMMUNOLOGICALS is operating at the current time. Most of BHARAT IMMUNOLOGICALS's value examination focuses on studying past and present price action to predict the probability of BHARAT IMMUNOLOGICALS's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move BHARAT IMMUNOLOGICALS's price. Additionally, you may evaluate how the addition of BHARAT IMMUNOLOGICALS to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go